Barrow Neurological Foundation is a 501(c)(3) organization based in Phoenix, Arizona, registered in 1962, with $83,572,452 in FY2023 revenue. CharityIndex grades it A, and it directs about 88% of spending to programs.
Revenue (FY2023)
$83.6M
▲ 143.9% vs prior year
Diseases median: $206K
Expenses (FY2023)
$37.9M
Net assets
$254.2M
Employees
0
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Barrow Neurological Foundation: 88% to programs · $2 to raise $100 earns a A+ on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Barrow Neurological Foundation: 81 mo reserves · +55% margin earns a B+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Barrow Neurological Foundation: 5 of 6 checks met earns a A on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Barrow Neurological Foundation: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
To support barrow neurological institute, a division of dignity health.
Neurotrials conducts research which is singularly focused on discovering new therapies for brain tumor patients through a broad portfolio of pharmacodynamic- and pharmacokinetic-driven clinical trials, combining industry-partnered drug development with the nation's largest operative brain tumor volume.
Revenue grew from $27.5M (FY2013) to $83.6M (FY2023) across 11 reported years.
Financial snapshot
Operating margin
54.7%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$264.2M
Total liabilities
$10.0M
Net assets
$254.2M
Salaries & benefits
$0
0% of expenses
Board members
39
38 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $83,572,452▲144% | $37,868,981▼32.6% | $254,169,308▲18.6% | $264,153,308▲16.8% | 990 |
| 2022 | $34,259,725▼36.7% | $56,151,491▲131% | $214,279,821▼4.5% | $226,235,827▼0.6% | 990 |
| 2021 | $54,095,366▼24.7% | $24,258,627▲2.1% | $224,407,715▼4.6% | $227,578,923▼4.3% | 990 |
| 2020 | $71,872,310▲125% | $23,763,761▼37.2% | $235,179,504▲41.2% | $237,891,027▲35.6% | 990 |
| 2019 | $31,938,606▲5.7% | $37,810,716▲32.2% | $166,519,627▼3.9% | $175,375,850▼3.1% | 990 |
| 2018 | $30,227,942▼33.2% | $28,610,001▲60.0% | $173,215,559▲0.5% | $181,054,579▲2.2% | 990 |
| 2017 | $45,243,552▲83.5% | $17,877,568▲28.4% | $172,404,492▲23.9% | $177,126,293▲23.6% | 990 |
| 2016 | $24,661,551▲34.4% | $13,920,811▼1.6% | $139,109,396▲18.4% | $143,335,154▲19.6% | 990 |
| 2015 | $18,350,163▼20.7% | $14,148,212▼0.1% | $117,516,658▼0.9% | $119,797,272▼2.4% | 990 |
| 2014 | $23,137,239▼15.7% | $14,165,441▼28.9% | $118,528,979▲7.0% | $122,738,530▲6.4% | 990 |
| 2013 | $27,454,548 | $19,928,213▲40.0% | $110,782,825▲11.2% | $115,408,419▲10.4% | 990 |
| 2012 | — | $14,233,622▼1.1% | $99,590,792▲11.6% | $104,505,202▲11.3% | 990 |
| 2011 | — | $14,389,699▲27.0% | $89,205,934▼2.9% | $93,933,843▼1.9% | 990 |
| 2010 | — | $11,330,075▼19.7% | $91,873,960▲36.7% | $95,752,103▲36.4% | 990 |
| 2009 | — | $14,114,352 | $67,196,726 | $70,181,224 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Katherine Cobb — $402,717 (1.06% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Katherine Cobb | President | 1 | $402,717 |
| Adam Levin | Director | 1 | — |
| Amanda Garmany | Director | 1 | — |
| Andy Mccain | Director | 1 | — |
| Bradley Grossman | Director | 1 | — |
| Chris Howard | Director | 1 | — |
| Dan Burns | Director | 1 | — |
| David Rauch | Director | 1 | — |
| David Van Denburgh | Director | 1 | — |
| Dionne Najafi | Director | 1 | — |
| Donna Johnson | Vice Chair | 1 | — |
| Earl Petznick Jr | Director | 1 | — |
| Ellen Katz | Board Secretary/ Director | 1 | — |
| Heidi J Teets | Director | 1 | — |
| Ira Fulton | Director | 1 | — |
| James Swanson | Treasurer | 1 | — |
| Janet Martin | Director | 1 | — |
| Jean Feuer | Director | 1 | — |
| Jonathan Levine | Director | 1 | — |
| Jordan Rose | Director | 1 | — |
| Contractor | Services | Paid |
|---|---|---|
| Mercer Investments LLC | Consulting | $215,750 |
| Milligan Lawless PC | Legal Services | $151,523 |
| Community Counseling Service Co LLC | Consulting | $137,500 |
146 grants to Barrow Neurological Foundation totaling $69.1M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Arizona Community Foundation | This award is designated support for the endowment of neurodegeneration research. | 2024 | $2,064,250 |
| Burton Family Foundation | Designated support for the barrow women's board: thurston innovation center | 2024 | $375,000 |
| National Charitable Endowment Inc | General charitable use | 2024 | $50,000 |
| Parkinsons Foundation Inc | Center of excellence grants | 2024 | $50,000 |
| Charities Aid Foundation America | Charitable donation | 2024 | $28,401 |
| Gs Donor Advised Philanthropy Fund For Wealth Management Inc | Medical / public services | 2024 | $26,000 |
| American Online Giving Foundation Inc | General support | 2024 | $19,519 |
| The Us Charitable Gift Trust | For recipient's exempt purpose | 2024 | $15,200 |
| American Endowment Foundation | Disease/disorder | 2024 | $15,000 |
| Parkinsons Foundation Inc | Clinical research | 2024 | $13,900 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $10,000 |
| Helios Education Foundation | See part iv | 2024 | $10,000 |
| Paypal Charitable Giving Fund | General support | 2024 | $9,733 |
| Independent Charitable Gift Fund | General support | 2024 | $5,500 |
| Dignity Health | Foundation support | 2023 | $6,317,798 |
1 grant totaling $20.8M in FY2023. All grants made by Barrow Neurological Foundation →
| Recipient | Purpose | Amount |
|---|---|---|
| Dignity Health | Support hospital | $20,770,004 |
Explore more
Data for Barrow Neurological Foundation (EIN 86-0174371) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.